They must be close to pulling the pin on the Northern Hemisphere flu season. They've stopped recruiting in Europe and I doubt they'd be recruiting many in Nth America.
We finally get to see the legend of the Inhibitex team display their powers of negotiation.
Can Russell convince FDA/BARDA to sign off on lower than expected enrolments? That's Russell's big fat KPI. If he fails then LANI loses some of its valuation.
Add to My Watchlist
What is My Watchlist?